Researcher profile

Kezhi Li

Kezhi Li contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
11topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2026arXiv

Development and Evaluation of HopeBot: an LLM-based chatbot for structured and interactive PHQ-9 depression screening

Static tools like the Patient Health Questionnaire-9 (PHQ-9) effectively screen depression but lack interactivity and adaptability. We developed HopeBot, a chatbot powered by a large language model (LLM) that administers the PHQ-9 using retrieval-augmented generation and real-time clarification. In a within-subject study, 132 adults in the United Kingdom and China completed both self-administered and chatbot versions. Scores demonstrated strong agreement (ICC = 0.91; 45% identical). Among 75 participants providing comparative feedback, 71% reported greater trust in the chatbot, highlighting clearer structure, interpretive guidance, and a supportive tone. Mean ratings (0-10) were 8.4 for comfort, 7.7 for voice clarity, 7.6 for handling sensitive topics, and 7.4 for recommendation helpfulness; the latter varied significantly by employment status and prior mental-health service use (p < 0.05). Overall, 87.1% expressed willingness to reuse or recommend HopeBot. These findings demonstrate voice-based LLM chatbots can feasibly serve as scalable, low-burden adjuncts for routine depression screening.

preprint2026arXiv

FairMedQA: Benchmarking Bias in Large Language Models for Medical Question Answering

Large language models (LLMs) are approaching expert-level performance in medical question answering (QA), demonstrating strong potential to improve public healthcare. However, underlying biases related to sensitive attributes such as sex and race pose life-critical risks. The extent to which such sensitive attributes affect diagnosis remains an open question and requires comprehensive empirical investigation. Additionally, even the latest Counterfactual Patient Variations (CPV) benchmark can hardly distinguish the bias levels of different LLMs. To further explore these dynamics, we propose a new benchmark, FairMedQA, and benchmark 12 representative LLMs. FairMedQA contains 4,806 counterfactual question pairs constructed from 801 clinical vignettes. Our results reveal substantial accuracy disparity ranging from 3 to 19 percentage points across sensitive demographic groups. Notably, FairMedQA exposes biases that are at least 12 percentage points larger than those identified by the latest CPV benchmark, presenting superior benchmarking sensitivity. Our results underscore an urgent need for targeted debiasing techniques and more rigorous, identity-aware validation protocols before LLMs can be safely integrated into practical clinical decision-support systems.

preprint2020arXiv

A novel hand-held interface supporting the self-management of Type 1 diabetes

The paper describes the interaction design of a hand-held interface supporting the self-management of Type 1 diabetes. It addresses well-established clinical and human-computer interaction requirements. The design exploits three opportunities. One is associated with visible context, whether conspicuous or inconspicuous. A second arises from the design freedom made possible by the user&#39;s anticipated focus of attention during certain interactions. A third opportunity to provide valuable functionality arises from wearable sensors and machine learning algorithms. The resulting interface permits ``What if?&#39;&#39; questions: it allows a user to dynamically and manually explore predicted short-term (e.g., 2 hours) relationships between an intended meal, blood glucose level and recommended insulin dosage, and thereby readily make informed food and exercise decisions. Design activity has been informed throughout by focus groups comprising people with Type 1 diabetes in addition to experts in diabetes, interaction design and machine learning. The design is being implemented prior to a clinical trial.

preprint2020arXiv

Basal Glucose Control in Type 1 Diabetes using Deep Reinforcement Learning: An In Silico Validation

People with Type 1 diabetes (T1D) require regular exogenous infusion of insulin to maintain their blood glucose concentration in a therapeutically adequate target range. Although the artificial pancreas and continuous glucose monitoring have been proven to be effective in achieving closed-loop control, significant challenges still remain due to the high complexity of glucose dynamics and limitations in the technology. In this work, we propose a novel deep reinforcement learning model for single-hormone (insulin) and dual-hormone (insulin and glucagon) delivery. In particular, the delivery strategies are developed by double Q-learning with dilated recurrent neural networks. For designing and testing purposes, the FDA-accepted UVA/Padova Type 1 simulator was employed. First, we performed long-term generalized training to obtain a population model. Then, this model was personalized with a small data-set of subject-specific data. In silico results show that the single and dual-hormone delivery strategies achieve good glucose control when compared to a standard basal-bolus therapy with low-glucose insulin suspension. Specifically, in the adult cohort (n=10), percentage time in target range [70, 180] mg/dL improved from 77.6% to 80.9% with single-hormone control, and to $85.6\%$ with dual-hormone control. In the adolescent cohort (n=10), percentage time in target range improved from 55.5% to 65.9% with single-hormone control, and to 78.8% with dual-hormone control. In all scenarios, a significant decrease in hypoglycemia was observed. These results show that the use of deep reinforcement learning is a viable approach for closed-loop glucose control in T1D.

preprint2014arXiv

Alternating Strategies Are Good For Low-Rank Matrix Reconstruction

This article focuses on the problem of reconstructing low-rank matrices from underdetermined measurements using alternating optimization strategies. We endeavour to combine an alternating least-squares based estimation strategy with ideas from the alternating direction method of multipliers (ADMM) to recover structured low-rank matrices, such as Hankel structure. We show that merging these two alternating strategies leads to a better performance than the existing alternating least squares (ALS) strategy. The performance is evaluated via numerical simulations.